Global mussel oils demand is anticipated to be valued at US$ 36 Million in 2022, forecast to grow at a CAGR of 3% to be valued at US$ 47.5 Million from 2022 to 2032. Growth is attributed to increased demand for mussel oils in a dietary supplement.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 33 Million |
| Expected Market Value (2022) | US$ 36 Million |
| Anticipated Forecast Value (2032) | US$ 47.5 Million |
| Projected Growth Rate (2022 to 2032) | 3% CAGR |
Mussel oil is derived from the green-lipped mussel, a bivalve mollusk, from the coast of New Zealand. Green-lipped mussel oil is native to the pristine seawaters of the coastline of New Zealand and is used in various treatments such as asthma and other respiratory problems, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease such as Crohn’s disease.
Mussel oil derived from the green-lipped mussel has been identified as a source of 25 different fatty acids, of which the omega-3 fatty acids comprise a significant composition. Thus, mussel oil has many health benefits and is widely used in dietary supplements and the cosmetics industry.
The USA is considered to be a highly lucrative market for mussel oils and its different products, driven primarily by its utilization across the cosmetics industries. Mussel oil is a rich source of omega-3 fatty acids which makes them suitable for application in dietary supplements.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The anti-inflammatory properties conveyed by the bioactive compounds present in the mussel oils have high demand in biopharmaceuticals. Mussel oil derived from green-lipped mussels contains a high amount of eicosatetraenoic acid since green-lipped mussel is the only known source of ETAs, which help prevent inflammation at a cellular level.
Increasing awareness about a healthy lifestyle and increased demand for dietary supplements drive the growth of the market. Oil extracted from green-lipped mussels found in the coastal line of New Zealand stimulates bone health and eliminates deficiencies as it is a rich source of protein, omega-3 fatty acids, selenium, iron, vitamin B12, iodine, magnesium, and calcium. Also, mussel oil helps in the treatment of asthma and other respiratory problems, rheumatoid arthritis osteoarthritis, and other inflammatory bowel diseases.
The Biopharmaceutical industry is expected to accrue significant benefits to the global mussel oils market as technological developments, cost-effective techniques are being developed to produce a supreme quality product with an improved long shelf-life of the mussel oil. Mussel oil can reduce the risk of heart disease thus used on large scale in pharmaceutics.
Although the mussel oils market has numerous end-user, there are numerous obstacles likely to pose a challenge to market growth. With increasing health awareness among the population consumers shifting toward a vegan lifestyle acts as a driver for the mussel oils market growth as it is animal-origin oil.
Lack of consumer awareness and lack of improved distribution channels may hinder the growth of the mussel oils market in forecasting years. The mussels count in oceans is affected by global warming, pollution, and exploitation by human activity this also hampers the growth of the market in forecasting years. Growing instances of allergies caused by seafood consumption are expected to slow down the mussel oils market growth.
Principal Consultant
The Asia Pacific was the largest market for mussel oils and the trend is expected to continue into the forecast period owing to high product demand in this region. The region is forecast to surge at a 3.3% CAGR from 2022 to 2032. China holds the largest share of mussel oil in the Asia Pacific region.
Increasing pet population and increasing mussel oils demand in pet food. Also, the rapidly increasing cosmetics industry provides a lucrative opportunity for the mussel oils market in the region.
According to Future Market Insights, Europe is expected to provide immense growth opportunities for mussel oils, with France expected to steer the bulk of all regional growth.
Extensive applications in dietary supplements are keeping sales of mussel oils afloat across France. Moreover, the pet food industry in these countries is also experiencing a major upsurge, which will generate favorable conditions for market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key participants present in the global mussel oils market include Waitaki Biosciences, Maclab, Aroma New Zealand Limited, Nature’s Range, Great Healthworks, and Blackmores Limited among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Waitaki Biosciences, Maclab, and Aroma New Zealand Limited account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3% from 2022 to 2032 |
| Market Value in 2022 | US$ 36 Million |
| Market Value in 2032 | US$ 47.5 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the global mussel oils market to expand at a 3% value CAGR by 2032
Asia Pacific is expected to be the most opportunistic mussel oils market, expanding at a 3.3% CAGR
Waitaki Biosciences, Maclab, Aroma New Zealand Limited, Nature’s Range, Great Healthworks, and Blackmores Limited are some prominent mussel oil manufacturers
1. Executive Summary | Mussel Oils Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and Their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyers
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) & Volume (Liters) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) & Volume (Liters) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End Use
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Liters) Analysis By End Use, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) & Volume (Liters) Analysis and Forecast By End Use, 2022 to 2032
5.3.1. Processed Food
5.3.2. Cosmetics and Personal Care
5.3.3. Biopharmaceutical
5.3.4. Dietary Supplements
5.3.5. Veterinary Medicine
5.3.6. Pet Food
5.4. Y-o-Y Growth Trend Analysis By End Use, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By End Use, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Liters) Analysis By Distribution Channel, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) & Volume (Liters) Analysis and Forecast By Distribution Channel, 2022 to 2032
6.3.1. Wholesale
6.3.2. Online Retailer
6.3.3. Supermarket
6.3.4. Specialty Stores
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Liters) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) & Volume (Liters) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Liters) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) & Volume (Liters) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By End Use
8.2.3. By Distribution Channel
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By End Use
8.3.3. By Distribution Channel
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Liters) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) & Volume (Liters) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By End Use
9.2.3. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By End Use
9.3.3. By Distribution Channel
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Liters) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) & Volume (Liters) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By End Use
10.2.3. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By End Use
10.3.3. By Distribution Channel
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Liters) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) & Volume (Liters) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. New Zealand
11.2.1.8. Rest of Asia Pacific
11.2.2. By End Use
11.2.3. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By End Use
11.3.3. By Distribution Channel
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Liters) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) & Volume (Liters) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of Middle East and Africa
12.2.2. By End Use
12.2.3. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By End Use
12.3.3. By Distribution Channel
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By End Use
13.1.2.2. By Distribution Channel
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By End Use
13.2.2.2. By Distribution Channel
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By End Use
13.3.2.2. By Distribution Channel
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By End Use
13.4.2.2. By Distribution Channel
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By End Use
13.5.2.2. By Distribution Channel
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By End Use
13.6.2.2. By Distribution Channel
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By End Use
13.7.2.2. By Distribution Channel
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By End Use
13.8.2.2. By Distribution Channel
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By End Use
13.9.2.2. By Distribution Channel
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By End Use
13.10.2.2. By Distribution Channel
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By End Use
13.11.2.2. By Distribution Channel
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By End Use
13.12.2.2. By Distribution Channel
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By End Use
13.13.2.2. By Distribution Channel
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By End Use
13.14.2.2. By Distribution Channel
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By End Use
13.15.2.2. By Distribution Channel
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By End Use
13.16.2.2. By Distribution Channel
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By End Use
13.17.2.2. By Distribution Channel
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By End Use
13.18.2.2. By Distribution Channel
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By End Use
13.19.2.2. By Distribution Channel
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By End Use
14.3.3. By Distribution Channel
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Waitaki Biosciences
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. Maclab
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. Aroma New Zealand Limited
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. Nature’s Range
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. Great Healthworks
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
15.1.6. Blackmores Limited
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.6.5.3. Channel Strategy
15.1.7. Bio-Mer Limited
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.7.5.3. Channel Strategy
15.1.8. ByLovely Health Ltd
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.8.5.2. Product Strategy
15.1.8.5.3. Channel Strategy
15.1.9. Henry Blooms Health Products
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.9.5.2. Product Strategy
15.1.9.5.3. Channel Strategy
15.1.10. Nature’s Range
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.10.5.2. Product Strategy
15.1.10.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Food and Beverage Insights
View Reports
Mussel Oils Market
